You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 300 Final analysis of a prospective, randomized, double-blind, placebo-controlled phase IIb trial of tumor lysate, particle-loaded, dendritic cell vaccine in stage III/IV melanoma: 36-month analysis

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials completed
300 Final analysis of a prospective, randomized, double-blind, placebo-controlled phase IIb trial of tumor lysate, particle-loaded, dendritic cell vaccine in stage III/IV melanoma: 36-month analysis

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020141014
Dec 20201804
Jan 20214004
Feb 20213608
Mar 20212404
Apr 20212206
May 2021102
Jun 2021004
Jul 2021002
Aug 2021004
Sep 2021007
Oct 202118019
Nov 202134014
Dec 20216404
Jan 20223007
Feb 20221804
Mar 202213104
Apr 20229306
May 20222606
Jun 20222605
Jul 2022806
Aug 20221205
Sep 20222605
Oct 20223605
Nov 2022603
Dec 20221600
Jan 20232403
Feb 20232002
Mar 20232407
Apr 20231002
May 2023401
Jun 2023601
Jul 20232204
Aug 20233803
Sep 2023201
Oct 20232605
Nov 20232001
Dec 20232402
Jan 20241801
Feb 20243202
Mar 202420013
Apr 20242008
May 20243004
Jun 20242601
Jul 20246407
Aug 20241406
Sep 20241605
Oct 20242804
Nov 20242806
Dec 20241405
Jan 20251409
Feb 2025603
Mar 2025006
Apr 2025002
May 2025005
Jun 2025006
Total13760277